CACNA1A and Alzheimer disease: We then showed that the partial genetic suppression of CaV2.1 was sufficient to normalize neurotransmitter release at hAPP synapses (Figures 5B and 5C), consistent with a critical mechanistic role for CaV2.1 in the enhancement of release in AD model mice in vivo.